← All trials
NCT05028478
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 22, 2021
- Primary completion
- Feb 10, 2023
- Completion date
- Oct 6, 2023
- First posted
- Aug 31, 2021
- Last posted
- Aug 31, 2021
- Enrollment
- 164
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Curon Biopharmaceutical (Australia) Co Pty LtdLead sponsor
- NovotechCollaborator
- Southern Medical Day Care CentreOverall official - principal investigator
- Cabrini Oncology ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.